Accessibility Menu
Dr. Martens Plc logo

Dr. Martens Plc(LSE) DOCS

Market Cap£754.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-80%
5 Year-81%
1 Year-13%
1 Month+5%
£0.80
+1.65%
+0.01Today
Dr. Martens Plc last closing stock price
MetricPriceDate
Last closeGBX 80.002026-08-26
Dr. Martens Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.54%GBX 85.602026-08-19
1 month+5.26%GBX 76.002026-07-27
3 month+8.84%GBX 73.502026-05-28
Year to date+4.44%GBX 76.602025-12-31
1 year-12.57%GBX 91.502025-08-26
3 year-47.88%GBX 153.502023-08-25
5 year-80.87%GBX 418.202021-08-27
Since inception-79.94%GBX 3.932021-01-29

Dr. Martens Plc Financials at a Glance

Market Cap

£754.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£1.55B

Net Income (TTM)

£28.30M

EPS (TTM)

£0.02

P/E Ratio

31.90

Dividend

£0.03

Beta (Volatility)

-0.04 (Low)

Price

£0.80

Volume

272,988

Open

£0.81

Previous Close

£0.79

Daily Range

£0.79 - £0.81

52-Week Range

£0.59 - £1.01

Estimated Earnings Date

Nov 26, 2026

DOCS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Dr. Martens Plc

Dr. Martens plc is a global footwear enterprise known for its iconic designs and craftsmanship. Established in 1945, the company operates internationally, offering a diverse range of footwear and accessories under the renowned Dr. Martens brand.

Products and Services
  • Classic 'Originals' footwear and contemporary 'fusion' styles
  • Children's shoes and casual designs
  • Various accessories complementing the footwear range
Growth Outlook
  • Revenue of £442.9 million reported in the latest quarter
  • Strong gross profit margin of 59% indicates effective cost management
  • Expansion into new markets supports long-term growth potential
Financial Highlights
  • Trailing twelve month (TTM) revenue of £1.5 billion reflects solid performance
  • Net income of £33.8 million in the latest quarter shows profitability
  • Dividend yield of 2.96% offers attractive returns for investors
Dr. Martens plc has established itself as a leader in the footwear industry, combining heritage with modern trends. The company's strong financial performance, highlighted by a recent revenue of £442.9 million and a net income of £33.8 million, underscores its resilience and market position. With a gross profit margin of 59%, Dr. Martens demonstrates effective cost management strategies that contribute to its profitability. The company's commitment to expanding into new markets further enhances its growth outlook, making it an intriguing option for potential investors. The dividend yield of 2.96% adds an additional layer of appeal, providing a steady return on investment. Overall, Dr. Martens plc presents a compelling case for those interested in the footwear sector.
AI Generated • Aug 12, 2026

Industry

Textiles, Apparel and Luxury Goods

Sector

Consumer Discretionary

Employees

2,377

CEO

Ije Nwokorie

Website

www.drmartensplc.com

Headquarters

London, GL NW1 7BY, GB

DOCS Financials

Key Financial Metrics (TTM)

Gross Margin

57.17%

Operating Margin

10.01%

Net Income Margin

3.11%

Return on Equity

6.89%

Return on Capital

9.72%

Return on Assets

2.71%

Earnings Yield

3.13%

Dividend Yield

3.24%

Payout Ratio

1.03%

Stock Overview

Market Cap

£754.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

957.13M

Volume

272.99K

Avg. Volume

1.47M

Financials (TTM)

Gross Profit

£949.00M

Operating Income

£132.70M

EBITDA

£255.60M

Operating Cash Flow

£303.30M

Capital Expenditure

-£17.60M

Free Cash Flow

£285.70M

Cash & ST Invst.

£180.30M

Total Debt

£393.50M

Dr. Martens Plc Performance Analysis

Dr. Martens Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31GBP 1,000,300,00010.1%
20242024-03-31GBP 877,100,000-12.3%
20252025-03-31GBP 787,600,000-10.2%
20262026-03-31GBP 766,200,000-2.7%
Dr. Martens Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-32.6%
Q42025-03-3042.6%
Q22025-09-30-30.5%
Q42026-03-3137.5%
Dr. Martens Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31GBP 0.13-28.7%
20242024-03-31GBP 0.07-45.5%
20252025-03-31GBP 0.00-93.4%
20262026-03-31GBP 0.02428.3%
Dr. Martens Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-142.5%
Q42025-03-30219.1%
Q22025-09-30-139.7%
Q42026-03-31432.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

£442.90M

-8.0%

Gross Profit

£261.60M

-18.3%

Gross Margin

59.07%

N/A

Market Cap

£754.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£317.30K

N/A

Employees

2,377

N/A

Net Income

£33.80M

-32.7%

EBITDA

£107.40M

+20.8%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

£180.30M

+62.3%

Total Debt

£393.50M

-16.0%

Accounts Receivable

£69.00M

+11.3%

Inventory

£160.80M

-36.8%

Long Term Debt

£347.30M

-17.6%

Short Term Debt

£46.20M

-1.7%

Return on Assets

2.71%

N/A

Return on Invested Capital

10.68%

N/A

Free Cash Flow

£136.60M

-26.2%

Operating Cash Flow

£141.60M

-26.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DOM.LDomino's Pizza Group plc
£2.11+2.13%
TRN.LTrainline Plc
£1.99+1.27%
XPS.LXPS Pensions Group plc
£3.15-0.47%
SMWH.LWH Smith PLC
£4.21+1.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
CRECre8 Enterprise
$6.60+1.57%
BITOProShares Trust - ProShares Bitcoin ETF
$10.50-0.01%
NVDANvidia
$210.97-0.01%
DAICCid HoldCo
$5.15+0.33%

Questions About DOCS

What is the current price of Dr. Martens Plc?

Dr. Martens Plc is trading at £0.80 per share.

What is the 52-week range for Dr. Martens Plc?

Over the past 52 weeks, Dr. Martens Plc has traded between £0.59 and £1.01.

How much debt does Dr. Martens Plc have?

As of the most recent reporting period, Dr. Martens Plc reported total debt of £391.40M.

How much cash does Dr. Martens Plc have on hand?

Dr. Martens Plc reported £180.30M in cash and cash equivalents in its most recent financial results.

What is Dr. Martens Plc’s dividend yield?

Dr. Martens Plc currently has a dividend yield of 3.24%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services